INTELLIGENCE ENGINE ACTIVE
Loading market intelligence...
Synchronizing institutional flows, real-time analytics & intelligence models
Market Wisdom & Tenets
Value Investing“Price is what you pay. Value is what you get.”
Warren Buffett
+10
🤖 Claude MCP on paid plans — NSE/BSE data, screeners & research in Claude Desktop & Claude Code.
✨ Setup guideConnecting to market data…
Synchronizing institutional flows, real-time analytics & intelligence models
“Price is what you pay. Value is what you get.”
Aggregating institutional notes, consensus estimates & financial filings
“Price is what you pay. Value is what you get.”
Live intelligence from Upstox & official NSE regulatory filings (XBRL), with Yahoo / SEC fallbacks for US names.
CIPLA LTD
₹1,391.80
Market closed · as of 00:55 IST · 14-11-2026
0 intraday points
Low
₹1,391.80
High
₹1,418.70
₹1,408.30
Previous close — your comparison point.
Down 1.17% from the previous close.
Data: Upstox
← Research home · Updated 11/13/2026, 7:25:19 PM
What changed. Why it matters. Where to verify.
A large share of earnings come from US generics sales.
Sector sensitivity +0.00
See rupee & currency →
Indian multinational pharmaceutical company
Cipla Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, paediatric and various other medical conditions. Cipla has 47 manufacturing locations across the world and sells its products in 86 countries. It is the third-largest drug producer in India.
Source: WikipediaReading filings for CIPLA…